Voices Against Brain Cancer Comments on a New Discovery of an Immunotherapy Target in Aggressive Brain Tumors

Voices Against Brain CancerNew York, NY, Sept. 2, 2013 – Voices Against Brain Cancer discusses the discovery of a new immunotherapy target in aggressive brain tumors that could help patients who do not respond to current chemotherapy.

According to an August 28, 2013 Med City News article titled “Researchers find new immunotherapy target in aggressive brain tumors,” researchers from Johns Hopkins School of Medicine have discovered that “a protein associated with melanomas and a variety of other cancers is also present in nearly 100 percent of malignant, aggressive forms of a common brain tumor – meningiomas.”

The discovery of the NY-ESO-1 protein is significant because “it could serve as a new target for immunotherapies for a cancer that does not respond to current chemotherapy.” According to the ClinicalTrials.gov website, there are approximately 66 clinical trials that are focusing on this protein. One particular study, being conducted at the National Cancer Institute, is designed to activate the immune systems of patients with other types of tumors that express the NY-ESO-1 protein in order to train the body to attack the cancer and destroy it.

Continue reading “Voices Against Brain Cancer Comments on a New Discovery of an Immunotherapy Target in Aggressive Brain Tumors”

Advertisements

Voices Against Brain Cancer Commends Neuropsychologist and Team for Research on Cognitive Brain-Training for Cancer Survivors

 

Voices Against Brain CancerNew York, NY – July 15, 2013 – On July 12, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Shelli Kesler, a Stanford University clinical neuropsychologist, and her colleagues for using brain-training software to help lift the mental fog caused by cancer treatment.

 

According to a July 2nd, 2013 Medcitynews.com article entitled “Brain-training software may help lift ‘chemo fog’ cause by cancer treatment,” “Chemo fog” is a mental fuzziness induced by repeated cancer treatment. Researchers say cognitive brain exercises can improve brain function and ease the effects of the recurring chemotherapy.

 

Researchers went on to say that “those who used a brain-training program for 12 weeks were more cognitively flexible, more verbally fluent, and faster-thinking than survivors who didn’t train.”

 

Continue reading “Voices Against Brain Cancer Commends Neuropsychologist and Team for Research on Cognitive Brain-Training for Cancer Survivors”